|
Dr. Fagan has served as a Synthetech director since 2001 and was appointed Chair of the Board in 2005 and Chief Executive Officer in November 2006. From January 1, 2004, until September 30, 2006, Dr. Fagan served as President and CEO and a director of PepTx, Inc., a biopharmaceutical company that is developing peptide based oncology therapeutics. Dr. Fagan will continue to serve as a Director of PepTx, Inc. From July 2001 through 2003, Dr. Fagan was President of ProGen Biologics LLC, a private biopharmaceutical company that develops healthcare solutions for people suffering from autoimmune diseases. In addition, Dr. Fagan has also been a consultant to the biopharmaceutical industry since November 2000. From 1992 to 2000, Dr. Fagan was employed as the General Manager of Peptides by Mallinckrodt, Inc., a subsidiary of Tyco International that manufactures bulk pharmaceuticals. From 1978 to 1991, he was employed in various capacities, including President from 1987 to 1991, of Sigma Chemical, a subsidiary of Sigma Aldrich Corporation that manufactures fine chemicals. Dr. Fagan holds a B.A. in Chemistry from Otterbein College and a Ph.D. in Chemistry from Case Western Reserve University. | 